Loading
Vaccine Development / Porcine Infection Models / Swine Diseases · Journal article
Virulence · July 28, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review of Streptococcus suis serotype 2 virulence research published over the past decade, organized by infection stage and virulence mechanisms. It synthesizes known pathogenic pathways, identifies knowledge gaps, and highlights controversies—such as conflicting phenotypes of regulatory systems and discrepancies between mouse models and natural porcine infection—rather than reporting new evidence to resolve them.
Narrative review article. Swine and humans; SS2 is a zoonotic pathogen causing meningitis, septicemia, and STSLS in both species..
SS2 case-fatality rate for streptococcal toxic shock-like syndrome (STSLS) exceeds 20%, with survivors often suffering permanent neurological sequelae including hearing loss and cognitive impairment Large-scale outbreaks in China during 1998 and 2005 resulted in over 200 human cases with high mortality Virulence repertoire has expanded to more than 200 genes and proteins, ranging from global regulators to moonlighting metabolic enzymes
Large-scale outbreaks in China during 1998 and 2005 resulted in over 200 human cases with high mortality
This review does not directly guide clinical practice but identifies regulatory and virulence mechanisms that may inform future vaccine and antivirulence therapeutic development. Clinicians should note that the field acknowledges major knowledge gaps, conflicting experimental results, and reliance on potentially unrepresentative mouse models, limiting confidence in translating findings to human or porcine infection management.
This is a narrative review synthesizing prior literature on S. suis serotype 2 virulence mechanisms; it raises questions and organizes existing knowledge rather than reporting new experimental evidence or clinical outcomes.
As stated by the source record.
Quoted from the source exactly as published.
This review does not directly guide clinical practice but identifies regulatory and virulence mechanisms that may inform future vaccine and antivirulence therapeutic development. Clinicians should note that the field acknowledges major knowledge gaps, conflicting experimental results, and reliance on potentially unrepresentative mouse models, limiting confidence in translating findings to human or porcine infection management.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Streptococcus suis serotype 2 is a major zoonotic pathogen causing meningitis, septicemia, streptococcal toxic shock-like syndrome (STSLS) in swine and humans. This review synthesizes discoveries over the past decade, organized around the infection progression, colonization, bloodstream survival, immune evasion, blood-brain barrier disruption, excessive inflammation culminating in STSLS. We dissect regulatory architecture including two-component systems, Ser/Thr kinase STK, small RNAs, toxin-antitoxin modules, and stringent response. We analyze functional effectors enabling niche adaptation, including capsule, pili, metabolic enzymes, metal acquisition systems, complement evasins, and suilysin. A dedicated section addresses critical controversies, including roles of CovR, phenotypes of SsnA and IdeS_suis, and dual functions of Fpr2. We evaluate translational implications, highlighting vaccine candidates and antivirulence targets. Knowledge gaps remain, including unknown targets of regulatory systems, unexplored post-translational modifications, discrepancies between mouse models and natural porcine infections. Future studies must prioritize natural-route infection models in pigs and systems-level approaches to translate discoveries into interventions.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.